Related Experiment Video
Updated: Dec 8, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
[Pulmonary blastomycosis]
Fatma Chermiti Ben Abdallah1, Imène Bachouch1, Nidhal Belloumi1
1Service de Pneumologie IV, Faculté de Médecine de Tunis, Hôpital Abderrahmen Mami Ariana, Tunis, Tunisie.
This case study details a rare Blastomycosis infection in Tunisia, mimicking tuberculosis. Early diagnosis and antifungal treatment with itraconazole led to patient recovery, highlighting diagnostic challenges.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- Blastomycosis is a rare fungal infection caused by *Blastomyces dermatitidis*, primarily affecting the lungs.
- Pulmonary blastomycosis presents with diverse clinical symptoms, from asymptomatic cases to life-threatening conditions.
Observation:
- A 35-year-old Tunisian patient presented with chronic cough, chest pain, fever, and weight loss.
- Physical examination revealed fever and a subcutaneous swelling near the T10 vertebra.
- Chest imaging showed bilateral opacities with excavations; sputum tests for tuberculosis were negative.
Findings:
- Anatomopathological examination of a dorsal mass biopsy confirmed Blastomycosis.
- Fungal cultures from the biopsy specimens validated the diagnosis.
- Treatment with itraconazole resulted in significant clinical and radiological improvement.
Implications:
- This case underscores the diagnostic difficulties of Blastomycosis in regions where it is uncommon, especially when symptoms overlap with tuberculosis.
- Timely diagnosis and appropriate antifungal therapy are crucial for favorable outcomes in Blastomycosis patients.
- Raising awareness among clinicians about rare fungal infections like Blastomycosis is essential for prompt management.
More Related Videos
02:46A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
Published on: January 20, 2023
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Other Pulmonary Disorders
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...